Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
LUMOS PHARMA, INC. (NLNK) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update",
"Second Quarter 2023 Financial Results"
05/03/2023 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates",
"First Quarter 2023 Financial Results"
03/01/2023 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports Full Year 2022 Financial Results, Provides Clinical Development Updates",
"Full Year 2022 Financial Results"
11/14/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/10/2022 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials",
"Full Year 2021 Financial Results"
11/03/2021 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates",
"Third Quarter 2021 November 3, 2021 2 Forward Looking Statements This"
08/05/2021 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates",
"Second Quarter 2021 Financial Results Presentation"
05/05/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
11/10/2020 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results • Lumos Pharma has initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in pediatric growth hormone deficiency patients with data read-out anticipated mid-year 2022",
"Third Quarter 2020 Financial Results Presentation"
08/13/2020 8-K Quarterly results
05/28/2020 8-K Investor presentation, Quarterly results
Docs: "Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities – Lumos Pharma expects to initiate its Phase 2b LUM-201 trial in Pediatric Growth Hormone Deficiency prior to the end of 2020 – Additional non-dilutive funds expected from anticipated monetization of priority review voucher – Cash on hand expected to fund current operations through Phase 2b trial read-out",
"First Quarter 2020 Financial Results Presentation"
02/28/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
07/30/2019 8-K Quarterly results
05/08/2019 8-K Investor presentation, Quarterly results
Docs: "NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update - Management to host conference call today at 4:30 p.m. ET",
"First Quarter 2019 Financial Results Presentation"
11/01/2018 8-K Investor presentation, Quarterly results
Docs: "NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings Management to Host Conference Call Today at 4:30 p.m. ET",
"Third Quarter 2018 Financial Results Presentation"
07/31/2018 8-K Investor presentation, Quarterly results
Docs: "NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance Management to Host Conference Call Today at 4:30 p.m. ET",
"Second Quarter 2018 Financial Results Presentation"
05/03/2018 8-K Investor presentation, Quarterly results
Docs: "NewLink Genetics Reports First Quarter 2018 Financial Results Management to Host Conference Call Today at 4:30 p.m. ET",
"First Quarter 2018 Financial Results Presentation"
11/02/2017 8-K Investor presentation, Quarterly results
Docs: "NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program - Management to Host Conference Call Today at 8:30 a.m. ET",
"Third Quarter 2017 Financial Results Presentation"
07/28/2017 8-K Form 8-K - Current report:
05/04/2017 8-K Form 8-K - Current report
11/01/2016 8-K Form 8-K - Current report
07/29/2016 8-K Form 8-K - Current report
04/29/2016 8-K Form 8-K - Current report
11/03/2015 8-K Quarterly results
Docs: "NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2015 Financial Results Management to Host Conference Call Today at 8:30 a.m. ET"
07/31/2015 8-K Quarterly results
Docs: "NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET-"
05/05/2015 8-K Quarterly results
Docs: "NewLink Genetics Corporation Provides Operational Update and Reports First Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET-"
11/06/2014 8-K Quarterly results
Docs: "NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results"
08/05/2014 8-K Quarterly results
Docs: "NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results"
05/06/2014 8-K Quarterly results
Docs: "NewLink Genetics Corporation Reports First Quarter 2014 Financial Results"
11/12/2013 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy